Histrelin acetate: gonadorelin analogue given once a year

Histrelin acetate (Vantas) is a gonadorelin analogue implant for the palliative treatment of advanced prostate cancer given once a year. In our New products review, Steve Chaplin presents the clinical data relating to its efficacy and adverse effects, and Mr Raj Persad considers its potential place in treatment. Copyright © 2010 Wiley Interface Ltd.